The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
EQRX INC | COM | 26886C107 | 27,035,109 | 13,935,623 | SH | SOLE | 13,935,623 | 0 | 0 | |||
INOGEN INC | COM | 45780L104 | 4,118,400 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 2,769,058 | 10,859,050 | SH | SOLE | 10,859,050 | 0 | 0 |